J Majtán1, L Majtánová, M Xu, V Majtán. 1. Department of Microbiology, Slovak Medical University, Bratislava, Slovak Republic. juraj.majtan@szu.sk
Abstract
AIMS: In this study, we examined the biofilm formation of 75 Salmonella enterica serovar Typhimurium (Salm. Typhimurium) human clinical isolates and the effect of subinhibitory concentrations (sub-MICs) of gentamicin, ciprofloxacin and cefotaxime on biofilm formation and exopolysaccharides (EPS) production. METHODS AND RESULTS: Quantification of biofilm formation and EPS production were carried out using a modified microtitre plate assay and spectrophotometric method, respectively. The results indicate that 38 isolates (50.7%), which are predominantly of DT104 phage type, presented as the strong biofilm producers in vitro on plastic surface. When strains with the highest biofilm-forming capacity were grown in the presence of sub-MICs of gentamicin and ciprofloxacin, the inhibition of biofilm formation and EPS production was observed. In contrast, cefotaxime at 1/2 MIC (0.039 microg ml(-1)) was able to significantly induce the production of biofilm as well as EPS in three isolates with nontypable and DT104 phage type, respectively. CONCLUSIONS: These results clearly indicate that all the three antibiotics tested are able to interfere with biofilm formation and EPS production by Salm. Typhimurium isolates. SIGNIFICANCE AND IMPACT OF THE STUDY: The current study demonstrated that cefotaxime at sub-MIC can be beneficial for the behaviour of pathogen Salm. Typhimurium in vitro.
AIMS: In this study, we examined the biofilm formation of 75 Salmonella enterica serovar Typhimurium (Salm. Typhimurium) human clinical isolates and the effect of subinhibitory concentrations (sub-MICs) of gentamicin, ciprofloxacin and cefotaxime on biofilm formation and exopolysaccharides (EPS) production. METHODS AND RESULTS: Quantification of biofilm formation and EPS production were carried out using a modified microtitre plate assay and spectrophotometric method, respectively. The results indicate that 38 isolates (50.7%), which are predominantly of DT104 phage type, presented as the strong biofilm producers in vitro on plastic surface. When strains with the highest biofilm-forming capacity were grown in the presence of sub-MICs of gentamicin and ciprofloxacin, the inhibition of biofilm formation and EPS production was observed. In contrast, cefotaxime at 1/2 MIC (0.039 microg ml(-1)) was able to significantly induce the production of biofilm as well as EPS in three isolates with nontypable and DT104 phage type, respectively. CONCLUSIONS: These results clearly indicate that all the three antibiotics tested are able to interfere with biofilm formation and EPS production by Salm. Typhimurium isolates. SIGNIFICANCE AND IMPACT OF THE STUDY: The current study demonstrated that cefotaxime at sub-MIC can be beneficial for the behaviour of pathogen Salm. Typhimurium in vitro.
Authors: Vitor O Silva; Larissa O Soares; Abelardo Silva Júnior; Hilário C Mantovani; Yung-Fu Chang; Maria Aparecida S Moreira Journal: Appl Environ Microbiol Date: 2014-07-25 Impact factor: 4.792
Authors: Uyen T Nguyen; Hanjeong Harvey; Andrew J Hogan; Alexandria C F Afonso; Gerard D Wright; Lori L Burrows Journal: Antimicrob Agents Chemother Date: 2014-08-18 Impact factor: 5.191
Authors: João Paulo Lopes de Andrade; Luiz de Macêdo Farias; João Fernando Gonçalves Ferreira; Oscar Bruna-Romero; Daniele da Glória de Souza; Maria Auxiliadora Roque de Carvalho; Kênia Valéria dos Santos Journal: Curr Microbiol Date: 2015-09-12 Impact factor: 2.188